95 related articles for article (PubMed ID: 9494558)
1. Intracavitary treatment of soft tissue sarcomas in dogs using cisplatin in a biodegradable polymer.
Dernell WS; Withrow SJ; Straw RC; Powers BE; Drekke JH; Lafferty M
Anticancer Res; 1997; 17(6D):4499-505. PubMed ID: 9494558
[TBL] [Abstract][Full Text] [Related]
2. Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas.
Havlicek M; Straw RS; Langova V; Dernell WS
Vet Comp Oncol; 2009 Jun; 7(2):122-9. PubMed ID: 19453366
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).
Bergman NS; Urie BK; Pardo AD; Newman RG
J Am Vet Med Assoc; 2016 May; 248(10):1148-56. PubMed ID: 27135671
[TBL] [Abstract][Full Text] [Related]
5. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
McSporran KD
Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
[TBL] [Abstract][Full Text] [Related]
6. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
10. Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 cases.
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Radiother Oncol; 2004 Dec; 73(3):313-9. PubMed ID: 15588876
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas.
Spugnini EP; Vincenzi B; Citro G; Santini D; Dotsinsky I; Mudrov N; Montesarchio V; Laieta MT; Esposito V; Baldi A
In Vivo; 2007; 21(5):819-22. PubMed ID: 18019417
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of one versus two treatments of local delivery cisplatin in a biodegradable polymer for canine osteosarcoma.
Mehl ML; Seguin B; Dernell WS; Lafferty M; Kass PH; Withrow SJ
Vet Comp Oncol; 2005 Jun; 3(2):81-6. PubMed ID: 19379216
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate intraoperative brachytherapy (IOHDR) using flab technique in the treatment of soft tissue sarcomas.
Rachbauer F; Sztankay A; Kreczy A; Sununu T; Bach C; Nogler M; Krismer M; Eichberger P; Schiestl B; Lukas P
Strahlenther Onkol; 2003 Jul; 179(7):480-5. PubMed ID: 12835885
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004).
Théon AP; Wilson WD; Magdesian KG; Pusterla N; Snyder JR; Galuppo LD
J Am Vet Med Assoc; 2007 May; 230(10):1506-13. PubMed ID: 17504043
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
17. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
18. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
[TBL] [Abstract][Full Text] [Related]
19. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
20. [The role of intraperitoneal chemotherapy after curative excision of primary abdominopelvic sarcoma].
Berthet B; Sugarbaker PH
Ann Chir; 1998; 52(7):607-11. PubMed ID: 9805797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]